sulpiride has been researched along with fluvoxamine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fennig, S; Fennig, SN; Pato, M; Weitzman, A | 1 |
| George, MS; Trimble, MR | 1 |
| Dereboy, F; Kaynak, H; Sevincok, L; Uslu, A | 1 |
| Baving, L; Schmidt, MH | 1 |
| Okuyama, S; Takamori, K; Yoshida, S | 1 |
| Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Ago, Y; Baba, A; Matsuda, T; Nakamura, S | 1 |
| Asai, K; Koeda, M; Okubo, Y; Suhara, T; Takahashi, H; Takano, A; Yahata, N | 1 |
| Iimori, M; Ikoshi, H; Masuya, J; Matsumiya, T; Takeda, H; Tsuji, M; Yamada, T | 1 |
| Ago, Y; Baba, A; Harasawa, T; Itoh, S; Matsuda, T; Nakamura, S | 1 |
| Bubl, B; Feuerstein, TJ; Hubbe, U; Huethe, F; Jackisch, R; Löffler, M; McIntosh, JM | 1 |
| Ago, Y; Baba, A; Matsuda, T; Nakamura, S; Sato, M | 1 |
| Ikenouchi-Sugita, A; Nakamura, J; Yoshimura, R | 1 |
| Mendhekar, DN | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Naguy, A | 1 |
1 review(s) available for sulpiride and fluvoxamine
| Article | Year |
|---|---|
[Review of pharmacological efficacies and side effects of antidepressants].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Fluvoxamine; Humans; Imipramine; Maprotiline; Paroxetine; Sulpiride; Trazodone | 2007 |
3 trial(s) available for sulpiride and fluvoxamine
| Article | Year |
|---|---|
Dystonic reaction associated with fluvoxamine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Sulpiride | 1993 |
Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2002 |
Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study.
Topics: Adult; Amisulpride; Amygdala; Brain; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Emotions; Fluvoxamine; Hemodynamics; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Single-Blind Method; Sulpiride | 2005 |
18 other study(ies) available for sulpiride and fluvoxamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
Topics: Adolescent; Arousal; Drug Therapy, Combination; Fluvoxamine; Humans; Loxapine; Male; Neurologic Examination; Obsessive-Compulsive Disorder; Recurrence; Sulpiride; Tourette Syndrome | 1994 |
Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
Topics: Antidepressive Agents, Second-Generation; Female; Fluvoxamine; Humans; Middle Aged; Obsessive-Compulsive Disorder; Sulpiride | 2000 |
[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Prefrontal Cortex; Retrospective Studies; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulpiride; Treatment Outcome | 2000 |
Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Escape Reaction; Fluvoxamine; Helplessness, Learned; Imipramine; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Sulpiride; Tetrahydronaphthalenes; Tranylcypromine | 2001 |
Drug-related hyperprolactinemia.
Topics: Antidepressive Agents; Antipsychotic Agents; Female; Flunarizine; Fluoxetine; Fluvoxamine; Humans; Hyperprolactinemia; Indoramin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sulpiride | 2003 |
Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
Topics: Animals; Antidepressive Agents, Second-Generation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Fluvoxamine; Haloperidol; Male; Microdialysis; Neostriatum; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Sulpiride | 2005 |
Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice.
Topics: Amygdala; Animals; Biogenic Monoamines; Brain; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Fluvoxamine; Indoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Pyridines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sulpiride; Time Factors | 2005 |
Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Combinations; Fluvoxamine; Hindlimb Suspension; Male; Mice; Motor Activity; Piperazines; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2005 |
Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adolescent; Adult; Aged; Alkaloids; Analysis of Variance; Animals; Autoreceptors; Azocines; Calcium; Child; Child, Preschool; Domperidone; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Feedback; Female; Fluvoxamine; Humans; In Vitro Techniques; Isoxazoles; Male; Maprotiline; Mice; Middle Aged; Neocortex; Nicotine; Nicotinic Antagonists; Potassium; Pyrrolidines; Quinolizines; Rats; Receptors, Nicotinic; Sulpiride; Time Factors; Tritium | 2006 |
Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Depression; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Loxapine; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulpiride; Time Factors | 2006 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2009 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
An Adult With Obsessive-Compulsive-Related Disorders and Tics Post-Carbon Monoxide Poisoning Who Responded Ultimately to Electroconvulsive Therapy.
Topics: Adult; Antipsychotic Agents; Carbon Monoxide Poisoning; Combined Modality Therapy; Electroconvulsive Therapy; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sulpiride; Tics; Treatment Outcome | 2019 |